Summary

Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.

Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.

Some prices, such as Merck’s diabetes drugs, will be reduced.

Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.

  • @cybervseas
    link
    English
    465 days ago

    They won’t even spend the money. It just builds up.

    • @Landless2029
      link
      385 days ago

      Its almost like dragons and thier hoards. Just keep piling it up…

      But they’re not magestic like dragons. Still close… Lizard people? Cold blooded. Predatory. It tracks.

      • @[email protected]
        link
        fedilink
        English
        85 days ago

        Somebody did the math already; Bezos alone has more money than is depicted in Smaugs hoard in The Hobbit

      • @blazeknave
        link
        15 days ago

        Huh. Wonder if that’s where the Icke stuff comes from. A line drawn from dragons.